Sven Hellberg — 11 Patents at Astrazeneca Ab

Sven Hellberg has been granted 11 US patents while listed as an inventor at Astrazeneca Ab. The first was granted in 2004 and the most recent in March 2010. Sven Hellberg ranks #435,149 of 4,157,543 US inventors in our database (top 10.5%). Patent records list Sven Hellberg in Dorotea, SE.

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
7683067	3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (GSK-3)	Stefan Berg	2010-03-23	$14,332,000
7595319	Compounds having selective inhibiting effect at GSK3	Stefan Berg, Peter Soderman	2009-09-29	$20,107,000
7595321	Compounds having selective inhibiting effect at GSK3	Stefan Berg	2009-09-29	$20,107,000
7585853	Compounds having selective inhibiting effect at GSK3	Stefan Berg, Peter Soderman	2009-09-08	$13,028,000
7399780	3-Heterocyclyl-indole inhibitors of glycogen synthase kinase-3	Stefan Berg, Martin Nylof, Yafeng Xue	2008-07-15	$34,444,000
7345050	Pyrimidine compounds	Stefan Berg	2008-03-18	$6,668,000
7342022	Compounds in the treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3	Stefan Berg, Ratan Bhat, Philip N. Edwards	2008-03-11	$4,855,000
7205314	Compounds for the treatment of dementia related diseases	Stefan Berg, Ratan Bhat, James Empfield, Michael Klimas, James R. Woods	2007-04-17	$15,383,000
7078410	2-arylamino-pyrimidines for the treatment of GSK3-related disorders	Stefan Berg, Ratan Bhat	2006-07-18	$22,831,000
7056939	4-(4Methoxybenzyl)-n′-(5-nitro1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3 (gsk3)	Stefan Berg	2006-06-06	$12,341,000
6747060	Non-natural galanin receptor ligands	Kulliki Saar, Tamas Bartfai, Ulo Langel, Gerd Hallnemo	2004-06-08

Sven Hellberg — 11 Patents

Issued Patents All Time

Patent Widget